brooksville pharmaceuticals semaglutide Study: 16 new obesity drugs could come to market in the next 5 years Ozempic Parent Company Novo Nordisk

Advise patients who are exposed to WEGOVY during pregnancy to contact Novo Nordisk at 1-877-390-2760 or www.wegovypregnancyregistry.com [see Use in Specific Populations (8.1)]

Complete titration schedule with syringe measurements Semaglutide dosing follows a gradual titration schedule

Here, additional data on the preventive health benefits of treating obesity will be key (e.g., SELECT trial for semaglutide) A company with asset(s) featuring compelling preclinical and clinical data demonstrating the above described profile could be positioned well to raise venture capital, even in todays challenging private financing market, and attract M&A activity from giants like Novo Nordisk and Eli Lilly

Yes, when administered by licensed professionals